Among the UPR branches, ATF6α has been shown to promote prostate cancer progression by upregulating PLA2G4A (cytosolic phospholipase A2)-mediated arachidonic acid metabolism, leading to elevated prostaglandin production and resistance to ferroptotic cell death in tumor cells [74]. This evidence concerns the gene ATF6 and neoplasm.